| Trial ID: | L0908 |
| Source ID: | NCT02030977
|
| Associated Drug: |
Resveratrol
|
| Title: |
The Effects of Resveratrol Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Fatty Liver
|
| Interventions: |
Dietary Supplement: Resveratrol;Other: placebo
|
| Outcome Measures: |
Alaninaminotransferase(ALT)nan
|
| Sponsor/Collaborators: |
Dr Azita Hekmatdoost
|
| Gender: |
All
|
| Age: |
18 Years80 Years
|
| Phases: |
Phase 2/Phase 3
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
|
| Start Date: |
29/12/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
--
|
| URL: |
http://clinicaltrials.gov/show/NCT02030977
|
